RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features

Area of Science:

• Immunology
• Genetics
• Gastroenterology

Background:

• Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) is crucial for regulating necroptosis and inflammatory pathways.
• Mutations in RIPK1 can lead to severe inflammatory conditions, but their specific role in early-onset inflammatory bowel disease (IBD) requires further elucidation.

Purpose of the Study:

• To investigate the clinical, genetic, and immunological characteristics of two patients with infantile-onset IBD caused by RIPK1 mutations.
• To analyze the impact of RIPK1 mutations on immune cell function and inflammatory responses in affected individuals.

Main Methods:

• Whole exome and Sanger sequencing were employed to identify genetic variants in two IBD patients.
• Mass cytometry time of flight (CyTOF) was used for detailed immunophenotyping of peripheral blood mononuclear cells from one patient, with comparisons to controls and Crohn's disease patients.
• Immunofluorescence RIPK1 staining was performed on rectal biopsies.

Main Results:

• Two patients presented with severe early-onset colitis and perianal fistulas, harboring pathogenic RIPK1 mutations.
• RIPK1 protein expression was significantly reduced or absent in rectal biopsies of the patients.
• CyTOF analysis revealed peripheral immune dysregulation, including increased IFNγ CD8+ T cells and decreased monocytes, dendritic cells, and B cells.
• RIPK1-deficient immune cells showed diminished IL-6 production in response to LPS.

Conclusions:

• RIPK1 mutations should be considered in the differential diagnosis of very young patients with colitis and perianal fistulas.
• The findings underscore RIPK1's critical role in intestinal immune homeostasis and suggest potential therapeutic targets.
• Further research is needed to define RIPK1's precise function in intestinal immunity and optimize treatment strategies for RIPK1 deficiency.